5-Bromo-4-chloro-1H-indol-3-yl alpha-D-galactopyranoside(CAS: 107021-38-5)

5-Bromo-4-chloro-1H-indol-3-yl alpha-D-galactopyranoside (CAS: 107021-38-5) must comply with GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a hazardous substance under GHS, requiring proper labeling and documentation. REACH regulations mandate detailed safety data sheets (SDS) and registration for substances above one tonne per annum. FDA and EPA regulations ensure that handling, storage, and disposal align with environmental protection standards.

When synthesizing 5-Bromo-4-chloro-1H-indol-3-yl alpha-D-galactopyranoside (CAS: 107021-38-5), chemists often consider alternative reagents like bromine and chloroacetic acid as starting materials. Isomers and analogs such as 4-bromo-5-chloro and 6-bromo-3-chloro derivatives can also be explored. These alternatives can offer similar functional groups but with different reactivity profiles, facilitating tailored synthesis strategies.

The research trend for 5-Bromo-4-chloro-1H-indol-3-yl alpha-D-galactopyranoside (CAS: 107021-38-5) indicates increasing interest in its use as a bioactive compound in drug discovery. Market trends show a growing focus on natural product analogs and derivatives for medicinal applications. Emerging research fields are exploring its potential in cancer therapy and as a precursor for other bioactive molecules. Price trends reflect the demand for these specialized compounds in academic and pharmaceutical research.

Waste containing 5-Bromo-4-chloro-1H-indol-3-yl alpha-D-galactopyranoside (CAS: 107021-38-5) should be collected in appropriate containers and stored separately to prevent contamination. Professional waste disposal services are recommended for incineration or safe chemical neutralization. Environmental protection measures include ensuring no spillage and proper labeling of waste. Compliance with local and international hazardous waste regulations is essential to minimize environmental impact.